Get the Stockscreener App
1.29
8.40%
0.10
Gain Therapeutics Inc Stock (GANX) Forecast
The Gain Therapeutics Inc (GANX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.5326, representing a +96.33% increase from the current price of $1.29. The highest analyst price target is $3.9489, and the lowest is $1.1163.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GANX Price Target
Average 2.0566
(+59.42% Upside)
Is Gain Therapeutics Inc (GANX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.48 | Neutral |
| STOCH(9,6) | 10.06 | Buy |
| STOCHRSI(14) | 52.66 | Neutral |
| MACD(12,26) | -0.1481 | Sell |
| ADX(14) | 30.61 | Sell |
| William %R | -77.42 | Neutral |
| CCI(14) | -62.92 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.345
Sell
|
1.3419
Sell
|
| MA20 |
1.5243
Sell
|
1.4686
Sell
|
| MA50 |
1.728
Sell
|
1.6372
Sell
|
| MA100 |
1.7585
Sell
|
1.7486
Sell
|
| MA200 |
1.893
Sell
|
1.8513
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, GANX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on GANX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.48 indicates that GANX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.06 indicates that GANX is oversold. This indicates that GANX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 52.66 indicates that GANX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.61 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -62.92 indicates that GANX is still oversold but not to an extreme extent.
Long-term GANX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Gain Therapeutics Inc financial reports and earnings history, Gain Therapeutics Inc (GANX) stock could reach $1.913 by 2030, $7.7959 by 2040 and $23.29 by 2050. See the projected annual prices until 2050 of the Gain Therapeutics Inc stock below:
- Gain Therapeutics Inc (GANX) is expected to reach an average price of $2.1226 in 2035, with a high prediction of $3.5131 and a low estimate of $3.3293. This indicates an $64.54% rise from the last recorded price of $1.29.
- Gain Therapeutics Inc (GANX) stock is projected to chart a bullish course in 2040, with an average price target of $8.108, representing an $528.52% surge from its current level. The forecast ranges from a conservative $8.0569 to a sky-high $7.7959.
- Our analysts predict Gain Therapeutics Inc (GANX) to jump 1,123% by 2045, soaring from $15.73 to an average price of $15.78, potentially reaching $15.92. While $15.73 is the low estimate, the potential upside is significant.
- Gain Therapeutics Inc (GANX) stock is expected to climb by 2050, reaching an average of $23.34, a $1,709% jump from its current level. However, a wide range of estimates exists, with high and low targets of $23.29 and $23.33, respectively, highlighting the market's uncertainty.
Gain Therapeutics Inc Stock (GANX) Year by Year Forecast
Gain Therapeutics Inc Stock (GANX) Price Forecast for 2026
The predicted value for Gain Therapeutics Inc (GANX) in 2026 is set at an average of $2.0566. Estimates vary from a peak of $3.9489 to a trough of $0.1642, indicating an +59.42% surge from the present price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.5216 | $1.1163 | $3.9489 | +17.95% |
| December, 2026 | $0.0418 | $0.1642 | $1.7906 | -96.76% |
Gain Therapeutics Inc Stock (GANX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Gain Therapeutics Inc (GANX) is $1.3079, with a high forecast of $2.3053 and a low forecast of $0.3105. This indicates an +1.39% increase from the last price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.2179 | $0.3105 | $0.6779 | -5.59% |
| February, 2027 | $1.3727 | $1.5227 | $1.3953 | +6.41% |
| March, 2027 | $2.0311 | $1.7891 | $1.7337 | +57.45% |
| April, 2027 | $1.1058 | $1.3758 | $1.4248 | -14.28% |
| May, 2027 | $1.8643 | $1.4595 | $1.6506 | +44.52% |
| June, 2027 | $2.249 | $2.3689 | $2.3053 | +74.34% |
| July, 2027 | $1.2438 | $1.6088 | $1.7127 | -3.58% |
| August, 2027 | $0.8822 | $1.3054 | $1.3411 | -31.61% |
| September, 2027 | $1.3569 | $1.0732 | $0.8169 | +5.19% |
| October, 2027 | $1.0717 | $1.4717 | $1.318 | -16.92% |
| November, 2027 | $1.7201 | $1.2554 | $1.4302 | +33.34% |
| December, 2027 | $1.7549 | $1.5362 | $1.5938 | +36.04% |
Gain Therapeutics Inc Stock (GANX) Price Forecast for 2028
In 2028, Gain Therapeutics Inc (GANX) is projected to reach an average price of $0.9175, with a high projection of $1.8256 and a low estimate of $0.00931. This indicates an -28.88% fall from the last price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.4833 | $1.7133 | $1.6559 | +14.98% |
| February, 2028 | $1.528 | $1.607 | $1.5407 | +18.45% |
| March, 2028 | $0.5228 | $0.7628 | $1.3717 | -59.47% |
| April, 2028 | $0.4075 | $0.6337 | $0.4788 | -68.41% |
| May, 2028 | $0.1741 | $0.3554 | $0.5041 | -86.51% |
| June, 2028 | $0.4093 | $0.00931 | $0.8203 | -68.27% |
| July, 2028 | $0.6709 | $0.3709 | $1.8256 | -47.99% |
| August, 2028 | $0.6161 | $0.1172 | $0.9817 | -52.24% |
| September, 2028 | $0.4814 | $0.0488 | $0.9024 | -62.68% |
| October, 2028 | $0.257 | $0.164 | $0.6276 | -80.07% |
| November, 2028 | $0.7118 | $0.5644 | $0.3044 | -44.82% |
| December, 2028 | $0.6165 | $0.6128 | $0.5055 | -52.21% |
Gain Therapeutics Inc Stock (GANX) Price Forecast for 2029
The 2029 price forecast for Gain Therapeutics Inc Stock (GANX) is $1.0219 on average, with a high prediction of $2.0282 and a low estimate of $0.0156. This represents an -20.78% decrease from the previous price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.985 | $0.7856 | $0.7448 | -23.65% |
| February, 2029 | $1.1097 | $1.0587 | $0.9423 | -13.98% |
| March, 2029 | $1.0245 | $1.5745 | $1.5008 | -20.59% |
| April, 2029 | $0.1729 | $0.3792 | $0.9693 | -86.60% |
| May, 2029 | $0.3424 | $0.0324 | $0.4661 | -73.46% |
| June, 2029 | $0.9576 | $0.252 | $1.7487 | -25.77% |
| July, 2029 | $0.3192 | $0.0992 | $1.6903 | -75.26% |
| August, 2029 | $0.3555 | $0.0156 | $0.6055 | -72.44% |
| September, 2029 | $0.6903 | $0.4829 | $0.4903 | -46.49% |
| October, 2029 | $1.9487 | $0.934 | $1.8587 | +51.06% |
| November, 2029 | $1.9635 | $1.9635 | $1.9411 | +52.21% |
| December, 2029 | $1.7719 | $2.0908 | $2.0282 | +37.36% |
Gain Therapeutics Inc Stock (GANX) Price Forecast for 2030
Gain Therapeutics Inc Stock (GANX) is expected to reach an average price of $1.1159 in 2030, with a high forecast of $1.913 and a low forecast of $0.3188. This signifies an -13.50% decrease from the last price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5616 | $1.7956 | $1.913 | +21.06% |
| February, 2030 | $1.1414 | $1.3477 | $1.4603 | -11.52% |
| March, 2030 | $0.3961 | $0.3824 | $0.7851 | -69.29% |
| April, 2030 | $0.9546 | $0.5798 | $0.9196 | -26.00% |
| May, 2030 | $0.9893 | $1.1919 | $1.0356 | -23.31% |
| June, 2030 | $0.4041 | $0.5704 | $0.4448 | -68.68% |
| July, 2030 | $0.3325 | $0.3188 | $0.3677 | -74.23% |
| August, 2030 | $0.1972 | $0.4007 | $0.4399 | -84.71% |
| September, 2030 | $0.6557 | $0.6609 | $0.672 | -49.17% |
| October, 2030 | $0.4504 | $0.3966 | $0.4515 | -65.09% |
| November, 2030 | $0.4051 | $0.5659 | $0.4915 | -68.59% |
| December, 2030 | $0.5536 | $0.4599 | $0.4625 | -57.09% |
0.68%
3.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):